Reflections on PMRC 2025: The AI Train Left the Station… “Next Stop”

Reflections on PMRC 2025: The AI Train Left the Station… “Next Stop”

I have attended more than half of the PMRC conferences held over the past 16 years. Being a veteran of the pharma market research industry, there have been many trends in research that have dominated this annual conference meeting, but this year was different. It wasn’t a trend being discussed, it was a reality – the recognition that AI is here and not going away.

I recall in last year’s meeting (yes, only a year ago!), there were a handful of discussions on the use of AI. The tone of these sessions was about how our industry (known to be a bit of a laggard for innovation) was grappling with the AI Train ready to roar out of the station. A conductor yelling “All Aboard” came to mind, with some ready to jump on and others quite hesitant. I recall a panel discussion of leaders from various client-side organizations and one member saying it scared them as much as Arnold Schwarzenegger’s character in the Terminator.

One year later, it is clear the AI Train has left the station, and it is not a matter of if you are getting on board, it’s a matter of when? At which “stop” will organizations board this supersonic speed train? 

Many agency side presentations this year suggest that most of us are using AI to support content writing and analysis (open-ends, qualitative discussions, etc.). In addition, there were discussions about developing personas with AI and the use of Digital Twins. A few talks provided comparisons of human analysis to AI analysis.

The mood of this conference was excitement, with the acknowledgment of the need to proceed with caution. There was a realization that AI will change the skillsets required to function as a value-add market researcher in this new world. One talk went as far as to suggest that adaptation is a must, much like Darwin and evolution, with a title of the talk named “I Have Said it Before and I Will Say it Again …You are Going to Lose Your Job (Or How Not To).

Being a seasoned researcher, I will admit that a year ago, I was standing on the station platform, intrigued with this AI Train and where it was going. This year, I am on board and excited to see the evolution of our industry, with the hope that we use our innate human intelligence to ensure we are responsible and balanced in our new relationship with our AI Research Accelerator (not Terminator)!  

Blogs & News

Read More
Read More

Unlocking Participant Engagement: The Key to Meaningful Market Research

In pharmaceutical market research, one element remains consistently crucial: participant…

Read More
Read More

Navigating Successful Real-World Evidence Publications: An Interdisciplinary Journey

Publishing real-world evidence (RWE) research involves a comprehensive journey of strategic…

Read More
Read More

Go from Exam Room Conversations to Actionable Healthcare Insights

Understanding what goes on in the exam room between patients and HCPs remains a critical yet…

Read More
Read More

Patient Voice Isn’t Optional, It’s the Future of RWE

Real-world evidence (RWE) is only as meaningful as the perspectives it includes. While healthcare…

Read More
Read More

4 Use Cases for Augmenting Primary Data with Synthetic Data in Pharma Market Research

Synthetic data is not new to market research, and the healthcare insights industry is starting to…

Read More
Read More

Beyond the Hype: How Digital Twins Are Transforming Market Research

Digital twins are reshaping the way we generate insights across industries. In this webinar, we…

Read More
Read More

5 Takeaways from an Intellus Newbie

Having spent 25 years in the consumer research sector (finance, CPG, retail, tech, etc), I am used…

Read More
Read More

10 Best Practices in Conducting Ethnography in Rare Disease Population

Rare disease patients face unique challenges that are often overlooked or misunderstood by those…

Read More
Read More

Building the Future: Why Qualitative Insights Will Thrive in the Age of AI

AI is transforming the way we collect and analyze qualitative data—but rather than replacing…

Read More
Read More

KJT Welcomes Katherine Ephlin as Research, Executive Vice President

KJT, a leader in strategic research insights, real-world evidence and medical communications for…

Let’s Take Research Further. Together.